arrow_back Trending Legislation
Share share

Affordable Insulin Act: Lower Costs for Patients

This act aims to reduce insulin costs for individuals covered by Medicare Part D and private health plans. It will lower out-of-pocket expenses for insulin, making essential treatment more accessible and easing the financial burden of diabetes.
Key points
Medicare Part D users will have a maximum monthly insulin cost of $35 starting October 1, 2022.
Private health plans, from January 1, 2023, cannot apply deductibles or charge more than $35 per month for insulin, or 25% of the negotiated price if lower.
Insulin cost-sharing payments will count towards annual deductibles and out-of-pocket maximums.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Affordable Insulin Now Act
Print number: S 3700
Sponsor: Sen. Warnock, Raphael G. [D-GA]
Process start date: 2022-02-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Affordable Insulin Act: Lower Costs for Patients

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 3700.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-02-17.

What are the main provisions?

Key points include:

  • Medicare Part D users will have a maximum monthly insulin cost of $35 starting October 1, 2022.
  • Private health plans, from January 1, 2023, cannot apply deductibles or charge more than $35 per month for insulin, or 25% of the negotiated price if lower.
  • Insulin cost-sharing payments will count towards annual deductibles and out-of-pocket maximums.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Warnock, Raphael G. [D-GA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 3700

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health